Table 1.
Gene name | Adjusted P-values of hub gene expression values | |||||
---|---|---|---|---|---|---|
Dataset 1 | Dataset 2 | |||||
CS vs. control | NLS vs. control | CS vs. NLS | DLE vs. control | Psoriasis vs. control | DLE vs. psoriasis | |
BTK | 0.008* | NS | 0.0115* | 0.0129* | 0.0357** | < 0.0001* |
CD86 | 0.0024* | NS | 0.0015* | 0.0001* | NS | 0.0005* |
ITGAL | 0.0057* | NS | 0.0015* | 0.0002* | NS | 0.0004* |
IL10RA | 0.0011* | NS | 0.0023* | 0.0004* | NS | 0.0002* |
SPI1 | 0.0008* | NS | 0.0035* | 0.0004* | NS | 0.0003* |
TLR1 | 0.0071* | NS | 0.0011* | 0.0153* | NS | < 0.0001* |
TNFRSF1B | 0.0017* | NS | 0.0027* | 0.0007* | 0.0252** | 0.0001* |
Increased expression level;
Decreased expression level.
CS, cutaneous sarcoidosis; NLS, non-lesional sarcoidosis lesion; DLE, discoid lupus erythematosus.